New Approach to Regenerative Medicine
Leveraging its proprietary non-invasive technology, SANUWAVE is well positioned to garner a share of multiple regenerative medicine market segments totaling $10 billion.
The Company has already completed a pivotal Phase III Investigational Device Exemption (IDE) clinical trial for the treatment of diabetic foot ulcers for its dermaPACE® device. The trial was very favorable, demonstrating statistically and clinically significant results. The dermaPACE® device to treat diabetic foot ulcers could be approved sometime in 1H12
Read more...
 
SG Better Than Advertised; Next Stop $0.50.
Nuvilex has been transformed from a cult-stock with a quirky history to an emerging, broad-based, multi-functional, therapeutic enhancement platform. Think back to the BASF commercials from the late 1990’s. “We don’t make….we make everything better.” In essence, that is what Nuvilex has with the live-cell encapsulation technology/delivery platform being acquired as part of the SG Austria transaction.
Read more...
 
From Zero to Sixty
Earlier this morning, SunSi Energies, Inc. announced solid fiscal 4Q11 and FY11 financial results that included the Company’s first-ever quarterly profit.
Read more...
 
One More Piece to the Puzzle
Early this morning, OHR announced that it was awarded a patent that includes claims related to composition of matter for the lactate salt form of Squalamine and its delivery using any pharmaceutically acceptable carrier.
Read more...
 
Raising Estimates on Fast Growing Stock

It should be a rough ride. But here is a company that is growing revenues at an amazing clip, prompting an increase in our forecast READMORE

 
Oculus Innovative Sciences, Inc. (NASDAQ:CM – OCLS)

1Q12 Results Preview; Company in Great Shape

On Thursday, August 4th, after the close, Oculus is slated to release 1Q12 results, for the period ending June 30, 2011.

While we expect results to be in line with our expectations, we believe investors should focus on the Company’s current positioning and trends, as Oculus is in great shape to achieve its objectives. Read More

 
<< Start < Prev 31 32 33 34 35 36 Next > End >>

Page 36 of 36